Isoxepac CAS 55453-87-7 Ubunyulu > 99.0% (HPLC) I-Olopatadine Hydrochloride Intermediate Factory
Umthengisi oPhambili we-Olopatadine Hydrochloride Intermediates
I-Olopatadine Hydrochloride CAS 140462-76-6
I-Isoxepac CAS 55453-87-7
[3-(Dimethylamino) propyl]triphenylphosphonium Bromide Hydrobromide CAS 27710-82-3
Please Contact: alvin@ruifuchem.com
| Igama leMchiza | I-Isoxepac |
| Izithethantonye | 6,11-Dihydro-11-Oxodibenzo[b,e]oxepin-2-Acetic Acid;6H-11-Oxodibenzo[b,e]oxepin-2-Acetic Acid;HP 549 |
| Ukungcola | Ukungcola kwe-Olopatadine 3;Olopatadine USP Related Compound C;Olapatadine EP Ukungcola C |
| Inombolo yeCAS | 55453-87-7 |
| Inombolo yeCAT | RF2697 |
| Ubume beStokhwe | KwiSitokhwe, Umthamo weMveliso iiToni ezingama-30 ngenyanga |
| Ifomula yeemolekyuli | C16H12O4 |
| Ubunzima beMolekyuli | 268.27 |
| Indawo yokunyibilika | 137.0 ~ 142.0℃ |
| Ukuxinana | 1.39 g/cm3 |
| Ukunyibilika | Inyibilika kwiMethanol |
| Uphawu | Ruifu Chemical |
| Into | Iinkcukacha |
| Imbonakalo | UkuKhanya-Omthubi ukuya kuMhlophe oMhlophe wePowder |
| Ukuchongwa | HPLC / UV |
| Ubunyulu / Indlela yokuHlalutya | >99.0% (HPLC) |
| Indawo yokunyibilika | 137.0 ~ 142.0℃ |
| Amanzi (nguKarl Fischer) | <0.50% |
| Ilahleko ekomisweni | <0.50% |
| Iintsimbi ezinzima | <20ppm |
| Ukungcola ngokupheleleyo | <1.00% |
| I-Infrared Spectrum | Iyahambelana neSakhiwo |
| Proton NMR Spectrum | Iyahambelana neSakhiwo |
| Umgangatho woVavanyo | Umgangatho woShishino |
| Ukusetyenziswa | Phakathi / Ukungcola kwe-Olopatadine Hydrochloride (CAS: 140462-76-6) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
Ukuthenga njani?Please contact: sales@ruifuchem.com or alvin@ruifuchem.com
Amava Eminyaka Eli-15?Sineminyaka engaphezu kwe-15 yamava ekwenziweni nasekuthumeleni kumazwe angaphandle uluhlu olubanzi oluphezulu lwamayeza aphakathi okanye amachiza alungileyo.
Iimarike eziphambili?Thengisa kwimarike yasekhaya, eMntla Melika, eYurophu, eIndiya, eRashiya, eKorea, eJapan, eOstreliya, njl.
Iingenelo?Umgangatho ophezulu, ixabiso elifikelelekayo, iinkonzo zengcali kunye nenkxaso yobugcisa, ukuhanjiswa ngokukhawuleza.
UmgangathoIsiqinisekiso?Inkqubo yokulawula umgangatho ongqongqo.Izixhobo zobuchwephesha zokuhlalutya ziquka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njl.
Iisampulu?Uninzi lweemveliso zibonelela ngeesampulu zasimahla zokuvavanya umgangatho, iindleko zokuthumela kufuneka zihlawulwe ngabathengi.
Factory Audit?Uphicotho-zincwadi lwasefektri wamkelekile.Nceda wenze idinga kwangaphambili.
MOQ?Akukho MOQ.Umyalelo omncinci wamkelekile.
Ixesha lokuzisa? Ukuba ngaphakathi kwesitokhwe, ukuhanjiswa kweentsuku ezintathu kuqinisekisiwe.
Ezothutho?Nge-Express (FedEx, DHL), ngoMoya, ngoLwandle.
Amaxwebhu?Emva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njl.
Udibaniso lweSiko?Inokubonelela ngeenkonzo zesiko lokudibanisa ukuze zilungele iimfuno zakho zophando.
Immimiselo yokuhlawula?I-invoyisi yeProforma iya kuthunyelwa kuqala emva kokuqinisekiswa kwe-odolo, efakwe kwiinkcukacha zethu zebhanki.Intlawulo nge-T / T (i-Telex Transfer), i-PayPal, i-Western Union, njl.
I-Isoxepac (i-CAS: 55453-87-7) iphakathi kwe-Olopatadine Hydrochloride (CAS: 140462-76-6).I-Olopatadine Hydrochloride yi-mast cell histamine release inhibitor kunye ne-H1 receptor antagonist ekhethiweyo.I-Olopatadine Hydrochloride tablets/capsules isetyenziswa kwi-allergic rhinitis, urticaria, pruritus (eczema, dermatitis, pruritus, psoriasis vulgaris, exudative erythema multiforme).I-Olopatadine Hydrochloride eye drops isetyenziselwa ukunyanga iimpawu ze-conjunctivitis ye-allergic.I-Olopatadine Hydrochloride liyeza elichasayo.Ineempembelelo ezimbini zokuthintela ukukhutshwa kwe-histamine kunye nokuzikhethela ngokuchasayo i-receptors ye-HI, kwaye ayinayo inhibition ye-nervous system kunye ne-cardiac toxic side effects eziqhelekileyo kunye ne-HI receptor antagonist antiallergic drugs.Ichiza alikwazi ukuthintela kuphela ukukhutshwa kwe-histamine kwiiseli zemasti, kodwa kwakhona lichasa i-H1 receptors ngokukhetha ngakumbi, kwaye ayinayo impembelelo kwi-α adrenergic receptors, i-dopamine receptors, kunye ne-M1 kunye ne-M2 receptors.Phakathi kwabo, imiphumo yecala le-nervous system imbalwa, isizukulwana esitsha seziyobisi ezichasene ne-antiallergic ezikhethiweyo.
